Enhancement of Silymarin Anti-fibrotic Effects by Complexation With Hydroxypropyl (HPBCD) and Randomly Methylated (RAMEB) β-Cyclodextrins in a Mouse Model of Liver Fibrosis

Gharbia, SamiBalta, CornelHerman, HildegardRosu, MarcelVáradi, JuditBácskay, IldikóVecsernyés, MiklósGyöngyösi, SzilviaFenyvesi, FerencVoicu, Sorina N.Stan, MirunaCristian, Roxana E.Dinischiotu, AncaHermenean, Anca2018-10-102018-10-102018Frontiers in Pharmacology. -9 (2018), p. 1-18. -Front. Pharmacol. - 1663-98121663-9812http://hdl.handle.net/2437/257561Enhancement of Silymarin Anti-fibrotic Effects by Complexation With Hydroxypropyl (HPBCD) and Randomly Methylated (RAMEB) β-Cyclodextrins in a Mouse Model of Liver Fibrosisfolyóiratcikkopen access journalhttp://webpac.lib.unideb.hu:8082/ebib/CorvinaWeb?action=cclfind&resultview=long&ccltext=idno+BIBFORM075559OrvostudományokGyógyszerészeti tudományokhttps://www.frontiersin.org/article/10.3389/fphar.2018.00883/fullszerzőhttp://dx.doi.org/10.3389/fphar.2018.008832018-10-1200044140980000185051666187